Michael Pervan

Array ( [id] => 6143281 [patent_doc_number] => 20110129883 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-02 [patent_title] => 'INACTIVATION OF GENES OF THE MEP PATHWAY' [patent_app_type] => utility [patent_app_number] => 13/008440 [patent_app_country] => US [patent_app_date] => 2011-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3584 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20110129883.pdf [firstpage_image] =>[orig_patent_app_number] => 13008440 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6014889 [patent_doc_number] => 20110223179 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-15 [patent_title] => 'METHODS AND COMPOSITIONS FOR MALARIA PROPHYLAXIS' [patent_app_type] => utility [patent_app_number] => 12/965622 [patent_app_country] => US [patent_app_date] => 2010-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 23270 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0223/20110223179.pdf [firstpage_image] =>[orig_patent_app_number] => 12965622 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7724183 [patent_doc_number] => 08097453 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-17 [patent_title] => 'Recombinant viral-based malaria vaccines' [patent_app_type] => utility [patent_app_number] => 12/928044 [patent_app_country] => US [patent_app_date] => 2010-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 14998 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/097/08097453.pdf [firstpage_image] =>[orig_patent_app_number] => 12928044 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6184051 [patent_doc_number] => 20110123570 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-26 [patent_title] => 'ACTINOBACILLUS SUIS ANTIGENS' [patent_app_type] => utility [patent_app_number] => 12/942579 [patent_app_country] => US [patent_app_date] => 2010-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13891 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20110123570.pdf [firstpage_image] =>[orig_patent_app_number] => 12942579 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6038510 [patent_doc_number] => 20110091559 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-21 [patent_title] => 'COMPOSITIONS COMPRISING ADJUVANT, MACROLIDE AND PROTEINACEOUS ANTIGEN AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/898009 [patent_app_country] => US [patent_app_date] => 2010-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8152 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20110091559.pdf [firstpage_image] =>[orig_patent_app_number] => 12898009 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7739435 [patent_doc_number] => 08105579 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-31 [patent_title] => 'Bacteriophage-containing therapeutic agents' [patent_app_type] => utility [patent_app_number] => 12/897741 [patent_app_country] => US [patent_app_date] => 2010-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 12996 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/105/08105579.pdf [firstpage_image] =>[orig_patent_app_number] => 12897741 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6087978 [patent_doc_number] => 20110217325 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-08 [patent_title] => 'T CELL EPITOPES OF THE CYN D 1 ALLERGEN FROM BERMUDA GRASS POLLEN' [patent_app_type] => utility [patent_app_number] => 12/871575 [patent_app_country] => US [patent_app_date] => 2010-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14500 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0217/20110217325.pdf [firstpage_image] =>[orig_patent_app_number] => 12871575 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6380404 [patent_doc_number] => 20100316662 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-16 [patent_title] => 'Methods and Compositions for Vaccination Comprising Nucleic Acid and/or Polypeptide Sequences of Chlamydia' [patent_app_type] => utility [patent_app_number] => 12/848535 [patent_app_country] => US [patent_app_date] => 2010-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 34172 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0316/20100316662.pdf [firstpage_image] =>[orig_patent_app_number] => 12848535 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7710991 [patent_doc_number] => 20120003652 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-05 [patent_title] => 'Essential genes encoding conserved metabolic pathway function in autotrophic solventogenic clostridial species' [patent_app_type] => utility [patent_app_number] => 12/803710 [patent_app_country] => US [patent_app_date] => 2010-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5778 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12803710 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6110126 [patent_doc_number] => 20110189146 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-04 [patent_title] => 'Methods of Use of Probiotic Lactobacilli for Companion Animals' [patent_app_type] => utility [patent_app_number] => 12/823463 [patent_app_country] => US [patent_app_date] => 2010-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7756 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0189/20110189146.pdf [firstpage_image] =>[orig_patent_app_number] => 12823463 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6262748 [patent_doc_number] => 20100297141 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'ANTI-ADHESIN BASED PASSIVE IMMUNOPROPHLACTIC' [patent_app_type] => utility [patent_app_number] => 12/822429 [patent_app_country] => US [patent_app_date] => 2010-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7202 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20100297141.pdf [firstpage_image] =>[orig_patent_app_number] => 12822429 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6351129 [patent_doc_number] => 20100331241 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-30 [patent_title] => 'Bacteriocins and Novel Bacterial Strains' [patent_app_type] => utility [patent_app_number] => 12/797796 [patent_app_country] => US [patent_app_date] => 2010-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12449 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0331/20100331241.pdf [firstpage_image] =>[orig_patent_app_number] => 12797796 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6149821 [patent_doc_number] => 20110021416 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => 'COMPOSITIONS, METHODS AND USES FOR TREATING BACTERIAL INFECTIONS' [patent_app_type] => utility [patent_app_number] => 12/790296 [patent_app_country] => US [patent_app_date] => 2010-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 23401 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20110021416.pdf [firstpage_image] =>[orig_patent_app_number] => 12790296 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6263026 [patent_doc_number] => 20100297182 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'Injectable Amino-acid Composition' [patent_app_type] => utility [patent_app_number] => 12/784245 [patent_app_country] => US [patent_app_date] => 2010-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 2979 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20100297182.pdf [firstpage_image] =>[orig_patent_app_number] => 12784245 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8642077 [patent_doc_number] => 08367055 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-05 [patent_title] => 'Immunogenic compositions against tuberculosis' [patent_app_type] => utility [patent_app_number] => 12/800374 [patent_app_country] => US [patent_app_date] => 2010-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 40 [patent_no_of_words] => 23238 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12800374 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6477525 [patent_doc_number] => 20100285057 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'HEAT TREATED BACTERINS, AND EMULSION VACCINES PREPARED FROM SUCH HEAT TREATED BACTERINS' [patent_app_type] => utility [patent_app_number] => 12/775749 [patent_app_country] => US [patent_app_date] => 2010-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4561 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0285/20100285057.pdf [firstpage_image] =>[orig_patent_app_number] => 12775749 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10844320 [patent_doc_number] => 08871494 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-10-28 [patent_title] => 'Over-production of secondary metabolites by over-expression of the VEA gene' [patent_app_type] => utility [patent_app_number] => 12/799505 [patent_app_country] => US [patent_app_date] => 2010-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 20 [patent_no_of_words] => 25079 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12799505 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7670602 [patent_doc_number] => 20110319871 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'INFECTIOUS DISEASE CELLULAR IMMUNOTHERAPY' [patent_app_type] => utility [patent_app_number] => 13/254059 [patent_app_country] => US [patent_app_date] => 2010-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5267 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13254059 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6418520 [patent_doc_number] => 20100167402 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'HUMAN SERUM FOR CELL CULTURE' [patent_app_type] => utility [patent_app_number] => 12/705298 [patent_app_country] => US [patent_app_date] => 2010-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4996 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20100167402.pdf [firstpage_image] =>[orig_patent_app_number] => 12705298 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6494817 [patent_doc_number] => 20100209526 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-19 [patent_title] => 'Product comprising a combination of milk serum apoproteins and free fatty acids' [patent_app_type] => utility [patent_app_number] => 12/657884 [patent_app_country] => US [patent_app_date] => 2010-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 9308 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20100209526.pdf [firstpage_image] =>[orig_patent_app_number] => 12657884 [rel_patent_id] =>[rel_patent_doc_number] =>)